H1 Blog

JULY 30, 2024

This effort seeks to provide the pharmaceutical industry with more accurate representation of patient populations, thereby enhancing the safety and efficacy for prescription drugs and medical devices. Hence, pharmaceutical companies need to start making preparations to ensure compliance with the new requirements.

FDA 59

FDA Clinical Trials Compliance Pharma Companies 59

ACTO

JUNE 29, 2023

Todd Amrhein Award-winning Director of Global Training, Learning and Development, Marketing, and Sales About Todd Amrhein : Todd is a results-driven, award-winning Director of Global Training, Learning and Development, Marketing, and Sales in the biotechnology and pharmaceutical industry.

International 52

International Marketing Production Science 52

H1 Blog

DECEMBER 18, 2023

Every year, we take a look at annual predictions to help life sciences, pharmaceutical, and healthcare companies understand larger industry trends and dynamics to prepare for the new year. These forecasts, curated by our own experts and thought leaders, shed light on the changes set to reshape the healthcare and pharmaceutical sectors.

Trials 64

Trials Clinical Trials FDA Pharmaceutical Companies 64

H1 Blog

JULY 24, 2023

Strategies for Market Access Teams One thing the healthcare ecosystem lacks in the United States is a system of shareable, actionable healthcare data. How do pharmaceutical companies work with payers? For more information about understanding payer and patient utilization trends, request a demo. The answer is payers and claims.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceuticals Treatment Pharmacy 52

H1 Blog

JUNE 8, 2023

Trusted Advisors for Scientific Exchange As pharmaceuticals strive to create medications that are more effective and accessible, it’s essential that they engage HCPs early in order to understand the needs of their target audiences.

Drug Development 52

Drug Development Science Pharmaceutical Companies Production 52

H1 Blog

SEPTEMBER 26, 2023

Predictive analytics has been gaining traction as a powerful tool in pharmaceuticals and biotechnology over the past few years, but its potential has yet to be fully realized when it comes to international clinical trials. Request a demo of Trial Landscape.

Trials 59

Trials Clinical Trials International Regulations 59

Agency IQ

DECEMBER 1, 2023

Expected Action Description of action Date Eudamed Module: Market Surveillance [E.U.] Completed development of the EUDAMED Market Surveillance module Q4 2023 Designation of E.U. Expected Action Description of action Original Deadline Pharmaceuticals – changes to marketing authorisations (review of EU rules) [E.U.]

Regulations 40

Regulations Clinical Trials Production Biosimilars 40